SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : NEOTHERAPEUTICS (NEOT) (NEOTW)
NEOT 1.919+4.3%Jan 17 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Lee Fredrickson who wrote (257)5/7/1998 7:13:00 PM
From: David M. Evans  Read Replies (2) of 705
 
You have summed up the feelings of the management in a nutshell, I suspect.

As I have said on many previous occasions, I would prefer a company that is short on hype and long on science, rather than the reverse <g>
Yes, it would be nice if the stock was worth more, but then I'd also like to be taller and better looking ...

There is a very good piece on NEOT in this month's NeuroInvestment newsletter. The author ventured in here some time ago, and was given short shrift for not hyping the stock, as we would expect him to do ... Actually, he was spot on in his last assessment that at $16 odd bucks, NEOT had gotten a little ahead of itself. I suspect that he's also fairly objective in his current assessment that the stock will be at $14 by year end, albeit a trifle conservative (that sounds like a political pudding?)

My guess is that it will be nearer $20 by year end, and I shall be the same height and no better looking.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext